DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Indoco Remedies Limited — Shareholders meeting

NSE 2 hrs ago·17 Sept 2026, 7:44 am

Indoco Remedies

Indoco Remedies Ltd held its annual general meeting on Sep 17 2026. The company has filed a notice with the stock exchange summarising the meeting’s proceedings, including any resolutions passed and shareholder votes.

For investors, the AGM is the forum where key matters such as appointment of directors, approval of financial statements, dividend policy and any strategic proposals are decided. Any changes approved can influence the company’s governance and future cash returns, so shareholders keep an eye on the outcomes.

Going forward, market participants should monitor the company’s next filing for the detailed minutes, look for any announced dividend, board changes or policy shifts, and watch how the stock reacts to those disclosures.